Drugmakers plead guilty to settle probe and must pay $435 million in fines
Drugmaker Schering-Plough Corp., the maker of allergy, cold, and cholesterol drugs, pled guilty to conspiracy to end a federal investigation into the marketing of some drugs for unapproved uses and overcharging Medicaid for certain drugs. Under the agreement, the drugmaker will pay $255 million towards civil aspects of its conspiracy. The remaining $180 million is a criminal fine which accompanies its plea of guilty to conspiracy. Investigators found evidence that the drugmaker marketed drugs for uses that were not approved by government regulators.